Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Greenhalf

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Clinical Genetics|April 24, 2010
PALB2 mutations in European familial pancreatic cancer familiesE P Slater, P Langer, E Niemczyk, et al.
British Journal of Cancer|January 7, 2010
Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancerC Dive, R A Smith, E Garner, et al.
The British Journal of Surgery|April 25, 2017
Accuracy of circulating histones in predicting persistent organ failure and mortality in patients with acute pancreatitisT Liu, W Huang, P Szatmary, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 18, 2002
Molecular diagnosis of early pancreatic ductal adenocarcinoma in high-risk patientsT Wong, N Howes, J Threadgold, et al.
Gut|June 24, 2005
Anticipation in familial pancreatic cancerC D McFaul, W Greenhalf, J Earl, et al.
Gut|May 6, 2010
CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancerS Ripka, A Neesse, J Riedel, et al.
The British Journal of Surgery|February 16, 2017
Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapyN T E Bird, M Elmasry, R Jones, et al.
Gene Therapy|August 18, 2001
Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastasesM J Humphreys, P Ghaneh, W Greenhalf, et al.
British Journal of Cancer|April 13, 2013
iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performanceS Tonack, C Jenkinson, T Cox, et al.
Journal of Proteomics|October 16, 2014
Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancerC Jenkinson, V Elliott, U Menon, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Clinical Genetics|April 24, 2010
PALB2 mutations in European familial pancreatic cancer familiesE P Slater, P Langer, E Niemczyk, et al.
British Journal of Cancer|January 7, 2010
Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancerC Dive, R A Smith, E Garner, et al.
The British Journal of Surgery|April 25, 2017
Accuracy of circulating histones in predicting persistent organ failure and mortality in patients with acute pancreatitisT Liu, W Huang, P Szatmary, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 18, 2002
Molecular diagnosis of early pancreatic ductal adenocarcinoma in high-risk patientsT Wong, N Howes, J Threadgold, et al.
Gut|June 24, 2005
Anticipation in familial pancreatic cancerC D McFaul, W Greenhalf, J Earl, et al.
Gut|May 6, 2010
CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancerS Ripka, A Neesse, J Riedel, et al.
The British Journal of Surgery|February 16, 2017
Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapyN T E Bird, M Elmasry, R Jones, et al.
Gene Therapy|August 18, 2001
Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastasesM J Humphreys, P Ghaneh, W Greenhalf, et al.
British Journal of Cancer|April 13, 2013
iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performanceS Tonack, C Jenkinson, T Cox, et al.
Journal of Proteomics|October 16, 2014
Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancerC Jenkinson, V Elliott, U Menon, et al.
Pageof 4